House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments
In Brief: ASCO Congratulates Klausner; UCLA Names Gasson Head Of Jonsson Center
Scientific Opportunity Should Guide Fund Allocation, House Says
House: NCI Should Coordinate National Cancer Program
ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer
ORI Finds Misconduct By CIT Professor
SAIC Frederick Offers Use Of Drug Facility
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









